Indo-Bangla Pharmaceuticals Limited reported earnings results for the year ended June 30, 2018. For the year, the company reported EPS of BDT 1.35, NAV per share of BDT 14.19 and NOCFPS of BDT 1.20 for the year ended on June 30, 2018 as against BDT 1.21, BDT 12.84 and BDT 1.09 respectively for the same period of the previous year.